Application of 5291-32-7, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, Application of 5291-32-7, molcular formula is C10H17NO3, introducing its new discovery.
USE OF ERIBULIN AND 3-QUINUCLIDINONE DERIVATIVES IN THE TREATMENT OF CANCER
The invention features methods for treating and preventing cancer (e.g., a p53-mutated cancer) in a patient in need thereof by administering eribulin (e.g., eribulin mesylate) in combination with a 3-quinuclidinone derivative (e.g., PRIMA-1 or PRIMA-1MET).
Because enzymes can increase reaction rates by enormous factors and tend to be very specific, Application of 5291-32-7, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about Application of 5291-32-7
Reference£º
Quinuclidine – Wikipedia,
Quinuclidine | C7H164N | ChemSpider